Trial intelligence / Profile preview

Preoperative Methylprednisolone in VATS for Lung Cancer

NCT03393949Phase 4Completed

Sponsor
Shengjing Hospital of China Medical University
Start
Jul 2015
Primary completion
Oct 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of methylprednisolone in postoperative pain, sponsored by Shengjing Hospital of China Medical University. Started Jul 2015; status: completed.

02

Drugs

methylprednisolone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03393949.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03393949.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call